Methacrylic Acid

Methacrylic Acid

SCHEMBL1023110

C=C(C)C(=O)O.C=C(C)C(=O)O.C=C(C)C(=O)O.[Ti]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.50
FFAR3 O14843 1/20 0.46
LCK P06239 1/20 0.46
FYN P06241 1/20 0.46
ALDH1A1 P00352 3/20 0.42
LMNA P02545 3/20 0.39
HSD17B10 Q99714 1/20 0.37
TSHR P16473 2/20 0.36
THPO P40225 1/20 0.36
CA1 P00915 3/20 0.33
TGFBR1 P36897 1/20 0.33
ALOX15 P16050 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
KDM4E B2RXH2 1/20 0.32
TET2 Q6N021 1/20 0.32
LDHA P00338 1/20 0.31
LDHB P07195 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL6437660 1.00 TDP1 (0.50) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL10484401 1.00 TDP1 (0.50) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL819744 1.00
Methacrylic Acid SCHEMBL11319477 0.96 TDP1 (0.47) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL491341 0.96 TDP1 (0.53) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL15005463 0.96 TDP1 (0.53) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL2230382 0.96 TDP1 (0.53) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL13234423 0.96
Methacrylic Acid SCHEMBL11235035 0.96 TDP1 (0.53) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL15043 0.96 TDP1 (0.53) TDP1FFAR3LCKFYNALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10159630-B2 Two- and three-component siloxane and related compounds and compositions KIMMERLING HOLDINGS GROUP, LLC (US) 2018-12-25 US disclosed
US-20160199266-A1 TWO- AND THREE-COMPONENT SILOXANE AND RELATED COMPOUNDS AND COMPOSITIONS KIMMERLING HOLDINGS GROUP, LLC 2016-07-14 US disclosed
US-9314407-B2 Two- and three-component siloxanes and related compounds and compositions KIMMERLING HOLDINGS GROUP, LLC (US) 2016-04-19 US disclosed
EP-2661648-A1 POLYHETEROSILOXANES FOR HIGH REFRACTIVE INDEX MATERIALS Dow Corning Corporation (US) 2013-11-13 EP disclosed
EP-2661647-A1 POLYHETEROSILOXANES FOR ANTIMICROBIAL MATERIALS Dow Corning Corporation (US) 2013-11-13 EP disclosed
US-20130230676-A1 Two- and Three-Component Siloxanes and Related Compounds and Compositions KIMMERLING HOLDINGS GROUP, LLC 2013-09-05 US disclosed
WO-2012094450-A1 POLYHETEROSILOXANES FOR HIGH REFRACTIVE INDEX MATERIALS DOW CORNING CORPORATION (US) 2012-07-12 WO disclosed
WO-2012094457-A1 POLYHETEROSILOXANES FOR ANTIMICROBIAL MATERIALS DOW CORNING CORPORATION (US) 2012-07-12 WO disclosed
EP-2448999-A1 METHODS FOR PREPARING POLYHETEROSILOXANES Dow Corning Corporation (US) 2012-05-09 EP disclosed
EP-1809706-B1 SUBSTRATE WITH AN ANTI-SOILING COATING ESSILOR INT (FR) 2012-05-02 EP disclosed
WO-2011002826-A1 METHODS FOR PREPARING POLYHETEROSILOXANES DOW CORNING CORPORATION (US) 2011-01-06 WO disclosed
US-7678464-B2 Substrate with anti-soiling coating ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) 2010-03-16 US disclosed
EP-1809706-A1 SUBSTRATE WITH AN ANTI-SOILING COATING ESSILOR INTERNATIONAL Compagnie Générale d'Optique (FR) 2007-07-25 EP disclosed
US-20070026237-A1 Substrate with anti-soiling coating ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) 2007-02-01 US disclosed
WO-2006045582-A1 SUBSTRATE WITH AN ANTI-SOILING COATING ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10159630-B2 Two- and three-component siloxane and related compounds and compositions ITGB3, ITGA2, ITGB2 TDP1 4755/4885FFAR3 2776/4885LCK 3320/4885
US-20130230676-A1 Two- and Three-Component Siloxanes and Related Compounds and Compositions ITGA2, ITGB3, ITGA4 TDP1 4762/4885FFAR3 2449/4885LCK 3794/4885
US-20160199266-A1 TWO- AND THREE-COMPONENT SILOXANE AND RELATED COMPOUNDS AND COMPOSITIONS ITGB3, ITGA2, ITGB2 TDP1 4755/4885FFAR3 2776/4885LCK 3320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.